Dry mouth, bad breath and tooth damage: the effects Ozempic and Wegovy can have on your mouth
Bad breath is a commonly reported side-effect of weight loss drugs. antoniodiaz/ Shutterstock Ozempic and Wegovy have been hailed as wonder drugs when it comes to weight loss. But as the drug has become more widely used, a number of unintended side-effects have become apparent – with the weight loss drug affecting the appearance of […]
What Is BMI: Body Mass Index Explained
BMI is calculated using your height and weight. It’s been criticized as a measurement of an individual’s health, but is being used to identify who qualifies for GLP-1 medications. Here’s everything you should know about BMI.
Popular weight loss drug raises risk of ‘silent’ cancer – study
New research has indicated a 33% higher incidence of kidney cancer among Ozempic users compared to non-users Ozempic and similar weight loss medications may increase the risk of kidney cancer, according to a major study. However, the drugs reportedly lower the risk of more than a dozen other cancers, suggesting their overall benefit may still […]
The Quantum Power of GLP-1 Peptides: Unlocking the Science that Leads to Lasting Weight Loss and Optimal Healthspan Paperback – June 3, 2025
by William A Seeds MD (Author) ($36.00) In The Quantum Power of GLP-1 Peptides: Unlocking the Science that Leads to Lasting Weight Loss and Optimal Healthspan, Dr. William A.Seeds uncovers the cellular mechanisms behind GLP-1s and other peptides that can help people lose significant weight and treat type-2 diabetes. Importantly, Dr. Seeds has also gathered peer-reviewed research that shows […]
Muscle mass loss during GLP1 receptor agonist therapy prevented with GDF8 and activin A blockade
Post Content
Eli Lilly inks deal with Camurus for its long-acting obesity tech
Eli Lilly has tapped Camurus in a deal worth up to $870 million for its drug delivery technology to develop four long-acting incretin candidates. The technology can be used on any of Lilly’s dual GLP …
State-dependent central synaptic regulation by GLP-1 is essential for energy homeostasis
Nature Metabolism, Published online: 04 June 2025; doi:10.1038/s42255-025-01305-x In this paper, the authors describe the energy state-dependent regulation of the PVNGLP-1R to DVC circuit, resulting in altered food intake and metabolic health, mediated by GLP-1 receptor signalling.
Advisory: Nutrition Priorities for GLP-1 Use in Obesity
Four clinical organizations jointly release an advisory with evidence-based nutrition and lifestyle interventions to enhance GLP-1 treatment outcomes for obesity. Medscape Medical News
Prediction: Eli Lilly Will Reach a $1 Trillion Valuation by 2027
Eli Lilly (NYSE: LLY) has been a growth beast over the years and is now easily the most valuable healthcare company in the world, with a market cap of more than $650 billion. But there’s still much more growth on the horizon for the business in the years ahead. Although as of this week the […]
Teen Wegovy prescriptions surge 50% in 1 year: Report
New prescriptions for Wegovy among teenagers increased by 50% between 2023 and 2024, according to a June 3 report from healthcare data company Truveta. To analyze GLP-1 utilization trends among adolescents, Truveta examined data from 1.2 million children aged 12 to 17 who had a recorded body mass index the same day as an outpatient […]